{"hands_on_practices": [{"introduction": "Microglia are not passive bystanders; they actively survey their environment using a sophisticated array of surface receptors. This exercise delves into the fundamental principles of receptor-ligand binding, which governs how microglia 'sense' chemical signals like fractalkine (CX3CL1). By applying the law of mass action, you will quantify how receptor occupancy changes with ligand concentration and predict the resulting impact on a key microglial function: process motility [@problem_id:5032410].", "problem": "Microglia, the resident immune cells of the central nervous system, express the C-X3-C motif chemokine receptor 1 (CX3CR1), a G protein-coupled receptor (GPCR) that binds soluble fractalkine (CX3CL1). At equilibrium, receptor–ligand binding can be described by the law of mass action for the reversible reaction $R + L \\rightleftharpoons RL$, where $R$ denotes free receptor, $L$ denotes free ligand, and $RL$ denotes the receptor–ligand complex. The dissociation constant $K_D$ is defined as $K_D = \\frac{[R][L]}{[RL]}$, and the fractional occupancy is $\\theta = \\frac{[RL]}{[R]_{\\text{tot}}}$, where $[R]_{\\text{tot}} = [R] + [RL]$ is the total receptor concentration. Assume a well-mixed extracellular space, steady-state equilibrium, no cooperativity, and that free ligand concentration is approximately equal to the applied concentration (that is, $[L] \\approx L_{\\text{applied}}$ because $[L] \\gg [R]_{\\text{tot}}$).\n\nYou are told that the dissociation constant is $K_D = 5\\ \\mathrm{nM}$ for soluble CX3CL1 binding to CX3CR1 on microglia. The soluble CX3CL1 concentration is set to $1\\ \\mathrm{nM}$, $10\\ \\mathrm{nM}$, and $100\\ \\mathrm{nM}$ in separate conditions. Starting from the definition of $K_D$ and the law of mass action, derive the expression for the fractional occupancy $\\theta$ as a function of $[L]$ and $K_D$, then compute $\\theta$ at $[L] = 1\\ \\mathrm{nM}$, $10\\ \\mathrm{nM}$, and $100\\ \\mathrm{nM}$.\n\nTo connect receptor occupancy to a functional outcome at the neuroimmune interface, use the following phenomenological model for the microglial process motility index $M$ (in $\\mu\\mathrm{m}\\ \\mathrm{min}^{-1}$): $M([L]) = M_0\\big(1 - \\alpha\\,\\theta([L])\\big)$, where $M_0 = 2.0\\ \\mu\\mathrm{m}\\ \\mathrm{min}^{-1}$ is the baseline motility in the absence of ligand and $\\alpha = 0.40$ quantifies the strength of CX3CR1-mediated motility suppression. Compute $M$ at $[L] = 1\\ \\mathrm{nM}$, $10\\ \\mathrm{nM}$, and $100\\ \\mathrm{nM}$ using your derived $\\theta([L])$.\n\nRound all numerical values to four significant figures. Express $\\theta$ as a dimensionless decimal (no percentage sign) and $M$ in $\\mu\\mathrm{m}\\ \\mathrm{min}^{-1}$. Provide your final answer as a single row matrix listing, in order, the three fractional occupancies followed by the three motility indices: $\\big(\\theta(1\\ \\mathrm{nM}),\\ \\theta(10\\ \\mathrm{nM}),\\ \\theta(100\\ \\mathrm{nM}),\\ M(1\\ \\mathrm{nM}),\\ M(10\\ \\mathrm{nM}),\\ M(100\\ \\mathrm{nM})\\big)$. Do not include units inside the final boxed answer.", "solution": "The user has provided a problem from the field of neurobiology, specifically concerning receptor-ligand kinetics and its effect on microglial motility. The problem is scientifically sound, well-posed, and contains all necessary information for a unique solution.\n\nFirst, we must derive the expression for the fractional occupancy, $\\theta$, as a function of the free ligand concentration, $[L]$, and the dissociation constant, $K_D$. The problem provides the following definitions and relationships:\nThe dissociation constant:\n$$K_D = \\frac{[R][L]}{[RL]}$$\nThe fractional occupancy:\n$$\\theta = \\frac{[RL]}{[R]_{\\text{tot}}}$$\nThe total receptor concentration:\n$$[R]_{\\text{tot}} = [R] + [RL]$$\nFrom the definition of the total receptor concentration, we can express the free receptor concentration, $[R]$, as:\n$$[R] = [R]_{\\text{tot}} - [RL]$$\nSubstituting this expression for $[R]$ into the equation for $K_D$:\n$$K_D = \\frac{([R]_{\\text{tot}} - [RL])[L]}{[RL]}$$\nOur goal is to find an expression for $\\theta = \\frac{[RL]}{[R]_{\\text{tot}}}$. We rearrange the equation to solve for this ratio.\n$$K_D [RL] = ([R]_{\\text{tot}} - [RL])[L]$$\n$$K_D [RL] = [R]_{\\text{tot}}[L] - [RL][L]$$\nGroup the terms containing $[RL]$:\n$$K_D [RL] + [RL][L] = [R]_{\\text{tot}}[L]$$\nFactor out $[RL]$ on the left-hand side:\n$$[RL](K_D + [L]) = [R]_{\\text{tot}}[L]$$\nTo obtain the expression for fractional occupancy, $\\theta$, we divide both sides by $[R]_{\\text{tot}}$ and by $(K_D + [L])$:\n$$\\frac{[RL]}{[R]_{\\text{tot}}} = \\frac{[L]}{K_D + [L]}$$\nTherefore, the derived expression for fractional occupancy is:\n$$\\theta([L]) = \\frac{[L]}{[L] + K_D}$$\nThis is the Hill-Langmuir equation for a system with no cooperativity.\n\nNext, we compute the numerical values for $\\theta$ at the specified ligand concentrations, using the given value $K_D = 5\\ \\mathrm{nM}$. The units of concentration (nM) cancel out, yielding a dimensionless fractional occupancy.\n\nFor $[L] = 1\\ \\mathrm{nM}$:\n$$\\theta(1) = \\frac{1}{1 + 5} = \\frac{1}{6} \\approx 0.16666...$$\nRounded to four significant figures, $\\theta(1\\ \\mathrm{nM}) = 0.1667$.\n\nFor $[L] = 10\\ \\mathrm{nM}$:\n$$\\theta(10) = \\frac{10}{10 + 5} = \\frac{10}{15} = \\frac{2}{3} \\approx 0.66666...$$\nRounded to four significant figures, $\\theta(10\\ \\mathrm{nM}) = 0.6667$.\n\nFor $[L] = 100\\ \\mathrm{nM}$:\n$$\\theta(100) = \\frac{100}{100 + 5} = \\frac{100}{105} = \\frac{20}{21} \\approx 0.95238...$$\nRounded to four significant figures, $\\theta(100\\ \\mathrm{nM}) = 0.9524$.\n\nFinally, we compute the microglial process motility index, $M$, for each of these conditions. The governing equation is given as:\n$$M([L]) = M_0\\big(1 - \\alpha\\,\\theta([L])\\big)$$\nwith the provided constants $M_0 = 2.0\\ \\mu\\mathrm{m}\\ \\mathrm{min}^{-1}$ and $\\alpha = 0.40$.\n\nFor $[L] = 1\\ \\mathrm{nM}$, using the calculated $\\theta \\approx 0.1667$:\n$$M(1) = 2.0 \\times (1 - 0.40 \\times 0.1667) = 2.0 \\times (1 - 0.06668) = 2.0 \\times 0.93332 = 1.86664$$\nUsing the exact fraction for intermediate calculation gives $M = 2.0 \\times (1 - 0.4 \\times \\frac{1}{6}) = 2.0 \\times (1 - \\frac{1}{15}) = 2.0 \\times \\frac{14}{15} = \\frac{28}{15} \\approx 1.86666...$\nRounded to four significant figures, $M(1\\ \\mathrm{nM}) = 1.867\\ \\mu\\mathrm{m}\\ \\mathrm{min}^{-1}$.\n\nFor $[L] = 10\\ \\mathrm{nM}$, using the calculated $\\theta \\approx 0.6667$:\n$$M(10) = 2.0 \\times (1 - 0.40 \\times 0.6667) = 2.0 \\times (1 - 0.26668) = 2.0 \\times 0.73332 = 1.46664$$\nUsing the exact fraction for intermediate calculation gives $M = 2.0 \\times (1 - 0.4 \\times \\frac{2}{3}) = 2.0 \\times (1 - \\frac{0.8}{3}) = 2.0 \\times (1 - \\frac{4}{15}) = 2.0 \\times \\frac{11}{15} = \\frac{22}{15} \\approx 1.46666...$\nRounded to four significant figures, $M(10\\ \\mathrm{nM}) = 1.467\\ \\mu\\mathrm{m}\\ \\mathrm{min}^{-1}$.\n\nFor $[L] = 100\\ \\mathrm{nM}$, using the calculated $\\theta \\approx 0.9524$:\n$$M(100) = 2.0 \\times (1 - 0.40 \\times 0.9524) = 2.0 \\times (1 - 0.38096) = 2.0 \\times 0.61904 = 1.23808$$\nUsing the exact fraction for intermediate calculation gives $M = 2.0 \\times (1 - 0.4 \\times \\frac{20}{21}) = 2.0 \\times (1 - \\frac{8}{21}) = 2.0 \\times \\frac{13}{21} = \\frac{26}{21} \\approx 1.238095...$\nRounded to four significant figures, $M(100\\ \\mathrm{nM}) = 1.238\\ \\mu\\mathrm{m}\\ \\mathrm{min}^{-1}$.\n\nThe final answer is the ordered set of the six computed values.", "answer": "$$\\boxed{\\begin{pmatrix} 0.1667 & 0.6667 & 0.9524 & 1.867 & 1.467 & 1.238 \\end{pmatrix}}$$", "id": "5032410"}, {"introduction": "Beyond individual signaling pathways, the overall functional identity of a microglia is defined by its 'state,' which is reflected in its pattern of gene expression. This practice problem introduces a simplified but powerful bioinformatics workflow used in modern neuroimmunology research to analyze RNA-sequencing data. You will learn how to normalize raw gene counts and use key markers, such as $\\text{P2ry12}$ and $\\text{Apoe}$, to calculate a state index that can distinguish a homeostatic microglia from one associated with disease [@problem_id:5032386].", "problem": "A research team is studying the transition of microglia from a homeostatic state to a disease-associated microglia (DAM) state during neurodegeneration. The DAM phenotype is empirically associated with reduced expression of homeostatic markers such as purinergic receptor P2Y12 ($\\text{P2ry12}$) and increased expression of apolipoprotein E ($\\text{Apoe}$). The team performs Ribonucleic Acid sequencing (RNA-seq) on fluorescence-activated cell sorted microglia from mouse brain and quantifies raw reads aligned to $\\text{P2ry12}$ and $\\text{Apoe}$ in two biological replicates per condition: control and disease. For each sample, the total microglia-aligned reads (library size) are also recorded.\n\nUse the following foundational bases and facts:\n- RNA-seq raw counts for a gene are proportional to its transcript abundance, modulated by library size. A simple and widely used normalization is counts per million (CPM), defined as the raw count divided by the library size, multiplied by $10^{6}$.\n- A fold-change compares the level of a quantity between two conditions as a ratio, and a base-$2$ logarithm of that ratio (log$_{2}$ fold-change) quantifies it on a symmetric scale where values greater than zero indicate an increase and values less than zero indicate a decrease.\n- In the context of microglia, a composite state index based on the ratio $\\text{Apoe}/\\text{P2ry12}$ can capture concurrent up-regulation of $\\text{Apoe}$ and down-regulation of $\\text{P2ry12}$; a positive log$_{2}$ fold-change of this ratio from control to disease indicates movement toward a DAM-like state.\n\nData for each sample $i$ consist of the triplet $(L_{i}, C_{i}^{\\text{P2ry12}}, C_{i}^{\\text{Apoe}})$:\n- Control replicate $1$: $(L_{1} = 12{,}000{,}000,\\; C_{1}^{\\text{P2ry12}} = 18{,}000,\\; C_{1}^{\\text{Apoe}} = 600)$.\n- Control replicate $2$: $(L_{2} = 10{,}000{,}000,\\; C_{2}^{\\text{P2ry12}} = 15{,}000,\\; C_{2}^{\\text{Apoe}} = 500)$.\n- Disease replicate $1$: $(L_{3} = 11{,}000{,}000,\\; C_{3}^{\\text{P2ry12}} = 4{,}400,\\; C_{3}^{\\text{Apoe}} = 6{,}600)$.\n- Disease replicate $2$: $(L_{4} = 13{,}000{,}000,\\; C_{4}^{\\text{P2ry12}} = 5{,}200,\\; C_{4}^{\\text{Apoe}} = 7{,}800)$.\n\nTask:\n1. For each sample, compute CPM-normalized values for $\\text{P2ry12}$ and $\\text{Apoe}$.\n2. For each condition (control, disease), compute the condition-level ratio $\\text{Apoe}/\\text{P2ry12}$ as the geometric mean across its two replicates of the per-sample CPM ratio $\\text{Apoe}/\\text{P2ry12}$.\n3. Compute the log$_{2}$ fold-change of the condition-level ratio from control to disease, defined as $\\log_{2}\\!\\left(\\dfrac{\\text{ratio}_{\\text{disease}}}{\\text{ratio}_{\\text{control}}}\\right)$.\n\nReport the final value of the log$_{2}$ fold-change as a single real number. Round your answer to four significant figures. No units are required.", "solution": "The problem is first validated to ensure it is scientifically grounded, well-posed, and objective. The provided information regarding microglia states (homeostatic vs. DAM), key genetic markers ($\\text{P2ry12}$, $\\text{Apoe}$), and the RNA-seq data analysis pipeline (normalization to CPM, calculation of fold-change) are all consistent with established principles in neurobiology and bioinformatics. The data are provided in a self-contained and complete manner, and the tasks are clearly defined. Therefore, the problem is deemed valid and a solution can be derived.\n\nThe overall objective is to compute the base-$2$ logarithm of the fold-change ($\\text{LFC}$) of a composite state index, defined as the ratio of expression of $\\text{Apoe}$ to $\\text{P2ry12}$, between a disease condition and a control condition.\n\nThe computation proceeds in three steps as outlined in the problem statement.\n\nStep 1: Compute CPM-normalized values.\nThe formula for Counts Per Million (CPM) is given as:\n$$ \\text{CPM}_{i}^{\\text{gene}} = \\frac{C_{i}^{\\text{gene}}}{L_{i}} \\times 10^{6} $$\nwhere $C_{i}^{\\text{gene}}$ is the raw count for a specific gene in sample $i$, and $L_{i}$ is the library size for that sample.\n\nFor the control samples:\n- Replicate 1 (sample $i=1$): $L_{1} = 12{,}000{,}000$, $C_{1}^{\\text{P2ry12}} = 18{,}000$, $C_{1}^{\\text{Apoe}} = 600$.\n$$ \\text{CPM}_{1}^{\\text{P2ry12}} = \\frac{18{,}000}{12{,}000{,}000} \\times 10^{6} = \\frac{18{,}000}{12} = 1500 $$\n$$ \\text{CPM}_{1}^{\\text{Apoe}} = \\frac{600}{12{,}000{,}000} \\times 10^{6} = \\frac{600}{12} = 50 $$\n- Replicate 2 (sample $i=2$): $L_{2} = 10{,}000{,}000$, $C_{2}^{\\text{P2ry12}} = 15{,}000$, $C_{2}^{\\text{Apoe}} = 500$.\n$$ \\text{CPM}_{2}^{\\text{P2ry12}} = \\frac{15{,}000}{10{,}000{,}000} \\times 10^{6} = \\frac{15{,}000}{10} = 1500 $$\n$$ \\text{CPM}_{2}^{\\text{Apoe}} = \\frac{500}{10{,}000{,}000} \\times 10^{6} = \\frac{500}{10} = 50 $$\n\nFor the disease samples:\n- Replicate 1 (sample $i=3$): $L_{3} = 11{,}000{,}000$, $C_{3}^{\\text{P2ry12}} = 4{,}400$, $C_{3}^{\\text{Apoe}} = 6{,}600$.\n$$ \\text{CPM}_{3}^{\\text{P2ry12}} = \\frac{4{,}400}{11{,}000{,}000} \\times 10^{6} = \\frac{4{,}400}{11} = 400 $$\n$$ \\text{CPM}_{3}^{\\text{Apoe}} = \\frac{6{,}600}{11{,}000{,}000} \\times 10^{6} = \\frac{6{,}600}{11} = 600 $$\n- Replicate 2 (sample $i=4$): $L_{4} = 13{,}000{,}000$, $C_{4}^{\\text{P2ry12}} = 5{,}200$, $C_{4}^{\\text{Apoe}} = 7{,}800$.\n$$ \\text{CPM}_{4}^{\\text{P2ry12}} = \\frac{5{,}200}{13{,}000{,}000} \\times 10^{6} = \\frac{5{,}200}{13} = 400 $$\n$$ \\text{CPM}_{4}^{\\text{Apoe}} = \\frac{7{,}800}{13{,}000{,}000} \\times 10^{6} = \\frac{7{,}800}{13} = 600 $$\n\nStep 2: Compute condition-level ratios.\nFirst, we find the per-sample ratio $R_{i}$ of the CPM values, $R_{i} = \\frac{\\text{CPM}_{i}^{\\text{Apoe}}}{\\text{CPM}_{i}^{\\text{P2ry12}}}$.\n- Control replicate 1: $R_{1} = \\frac{50}{1500} = \\frac{1}{30}$.\n- Control replicate 2: $R_{2} = \\frac{50}{1500} = \\frac{1}{30}$.\n- Disease replicate 1: $R_{3} = \\frac{600}{400} = \\frac{3}{2}$.\n- Disease replicate 2: $R_{4} = \\frac{600}{400} = \\frac{3}{2}$.\n\nNext, we calculate the condition-level ratio as the geometric mean of the per-sample ratios for each condition.\n- For the control condition:\n$$ \\text{ratio}_{\\text{control}} = \\sqrt{R_{1} \\times R_{2}} = \\sqrt{\\frac{1}{30} \\times \\frac{1}{30}} = \\frac{1}{30} $$\n- For the disease condition:\n$$ \\text{ratio}_{\\text{disease}} = \\sqrt{R_{3} \\times R_{4}} = \\sqrt{\\frac{3}{2} \\times \\frac{3}{2}} = \\frac{3}{2} $$\n\nStep 3: Compute the log$_{2}$ fold-change.\nThe log$_{2}$ fold-change ($\\text{LFC}$) is defined as $\\log_{2}\\!\\left(\\frac{\\text{ratio}_{\\text{disease}}}{\\text{ratio}_{\\text{control}}}\\right)$.\n$$ \\text{LFC} = \\log_{2}\\!\\left(\\frac{\\frac{3}{2}}{\\frac{1}{30}}\\right) = \\log_{2}\\!\\left(\\frac{3}{2} \\times 30\\right) = \\log_{2}(45) $$\nTo find the numerical value, we can use the change of base formula for logarithms: $\\log_{b}(x) = \\frac{\\ln(x)}{\\ln(b)}$.\n$$ \\text{LFC} = \\frac{\\ln(45)}{\\ln(2)} \\approx \\frac{3.80666}{0.693147} \\approx 5.49185 $$\nRounding the result to four significant figures gives $5.492$. The positive value indicates a shift towards the DAM state, as expected from the raw data.", "answer": "$$\\boxed{5.492}$$", "id": "5032386"}, {"introduction": "The functional states of microglia have profound consequences for the health of the entire central nervous system. This final exercise models one of their most critical protective roles: the phagocytic clearance of pathological proteins like amyloid-beta ($A\\beta$), a hallmark of Alzheimer's disease. By constructing a simple production-clearance model, you will calculate how a genetic impairment affecting the microglial receptor TREM2 disrupts this crucial balance, leading to a build-up of toxic $A\\beta$ in the brain [@problem_id:5032426].", "problem": "Microglia are central innate immune cells of the central nervous system, and their receptor Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) modulates phagocytic clearance of extracellular amyloid-beta (Aβ). Consider extracellular Aβ dynamics in brain interstitial fluid modeled as a steady-state production–clearance system where production is constant and clearance is the sum of independent first-order processes: microglial phagocytosis and non-microglial routes such as proteolytic degradation and cerebrospinal fluid efflux. Assume amyloid-beta (Aβ) is produced at a constant rate of $1.2$ nM per hour, the baseline microglial phagocytosis rate constant is $0.05$ per hour, and the baseline non-microglial clearance rate constant is $0.10$ per hour. A TREM2 (Triggering Receptor Expressed on Myeloid Cells 2) loss-of-function variant reduces the microglial phagocytosis rate constant by a fraction $0.40$ of its original value. Using only first principles of mass balance at steady state and the definition of first-order clearance, compute the predicted increase in the extracellular Aβ steady-state concentration (new steady-state minus baseline). Express your final answer in nM and round to four significant figures.", "solution": "The problem asks for the increase in the steady-state concentration of extracellular amyloid-beta (Aβ) due to a loss-of-function variant in the TREM2 receptor. The problem is well-posed and scientifically grounded in a simplified kinetic model of protein homeostasis. We can solve this using first principles of mass balance at steady state.\n\nLet $C(t)$ represent the concentration of Aβ in the brain interstitial fluid at time $t$. The dynamics of $C(t)$ can be described by a differential equation that balances production and clearance:\n$$\n\\frac{dC}{dt} = (\\text{Rate of Production}) - (\\text{Rate of Clearance})\n$$\nThe problem states that Aβ is produced at a constant rate, which we denote by $P$.\n$$\nP = 1.2 \\, \\text{nM/hour}\n$$\nThe clearance is described as a first-order process, meaning the rate of clearance is proportional to the concentration $C$. The total rate of clearance is the sum of two independent first-order processes: microglial phagocytosis and non-microglial routes. Let $k_{micro}$ be the rate constant for microglial phagocytosis and $k_{non-micro}$ be the rate constant for non-microglial clearance. The total clearance rate constant, $k_{total}$, is their sum:\n$$\nk_{total} = k_{micro} + k_{non-micro}\n$$\nThe rate of clearance is therefore $k_{total} C(t)$. The mass balance equation becomes:\n$$\n\\frac{dC}{dt} = P - k_{total} C\n$$\nAt steady state, the concentration of Aβ is constant, which means its rate of change is zero:\n$$\n\\frac{dC_{ss}}{dt} = 0\n$$\nSubstituting this into the mass balance equation gives:\n$$\n0 = P - k_{total} C_{ss}\n$$\nSolving for the steady-state concentration, $C_{ss}$, we get:\n$$\nC_{ss} = \\frac{P}{k_{total}} = \\frac{P}{k_{micro} + k_{non-micro}}\n$$\nFirst, we calculate the baseline steady-state concentration, $C_{ss, base}$, using the given baseline rate constants:\n$$\nk_{micro, base} = 0.05 \\, \\text{hour}^{-1}\n$$\n$$\nk_{non-micro} = 0.10 \\, \\text{hour}^{-1}\n$$\nThe baseline total clearance rate constant is:\n$$\nk_{total, base} = k_{micro, base} + k_{non-micro} = 0.05 \\, \\text{hour}^{-1} + 0.10 \\, \\text{hour}^{-1} = 0.15 \\, \\text{hour}^{-1}\n$$\nThe baseline steady-state concentration is:\n$$\nC_{ss, base} = \\frac{P}{k_{total, base}} = \\frac{1.2 \\, \\text{nM/hour}}{0.15 \\, \\text{hour}^{-1}} = 8 \\, \\text{nM}\n$$\nNext, we consider the effect of the TREM2 loss-of-function variant. It reduces the microglial phagocytosis rate constant by a fraction $f = 0.40$ of its original value. The new microglial rate constant, $k_{micro, new}$, is:\n$$\nk_{micro, new} = k_{micro, base} \\times (1 - f) = 0.05 \\, \\text{hour}^{-1} \\times (1 - 0.40) = 0.05 \\, \\text{hour}^{-1} \\times 0.60 = 0.03 \\, \\text{hour}^{-1}\n$$\nThe non-microglial clearance rate constant remains unchanged. The new total clearance rate constant, $k_{total, new}$, is:\n$$\nk_{total, new} = k_{micro, new} + k_{non-micro} = 0.03 \\, \\text{hour}^{-1} + 0.10 \\, \\text{hour}^{-1} = 0.13 \\, \\text{hour}^{-1}\n$$\nThe new steady-state concentration, $C_{ss, new}$, is:\n$$\nC_{ss, new} = \\frac{P}{k_{total, new}} = \\frac{1.2 \\, \\text{nM/hour}}{0.13 \\, \\text{hour}^{-1}} = \\frac{1.2}{0.13} \\, \\text{nM}\n$$\nThe problem asks for the increase in the steady-state concentration, which is the difference between the new and baseline concentrations, $\\Delta C_{ss}$:\n$$\n\\Delta C_{ss} = C_{ss, new} - C_{ss, base}\n$$\n$$\n\\Delta C_{ss} = \\left( \\frac{1.2}{0.13} - 8 \\right) \\, \\text{nM}\n$$\nTo compute the value:\n$$\n\\Delta C_{ss} = (9.23076923... - 8) \\, \\text{nM} = 1.23076923... \\, \\text{nM}\n$$\nThe problem requires the answer to be rounded to four significant figures.\n$$\n\\Delta C_{ss} \\approx 1.231 \\, \\text{nM}\n$$\nThe predicted increase in the extracellular Aβ steady-state concentration is $1.231$ nM.", "answer": "$$\\boxed{1.231}$$", "id": "5032426"}]}